We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
-15.38%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$1.73B
AUM Growth
-$639M
Cap. Flow
-$140M
Cap. Flow %
-8.12%
Top 10 Hldgs %
22.44%
Holding
369
New
31
Increased
82
Reduced
96
Closed
156

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$26.8M
2
SAIC icon
Saic
SAIC
+$21.7M
3
GNRC icon
Generac Holdings
GNRC
+$17M
4
BLD
TopBuild
BLD
+$13.5M
5
ONTO icon
Onto Innovation
ONTO
+$12.4M

Sector Composition

Rank Sector Weight
1 Healthcare 26.76%
2 Technology 15.82%
3 Industrials 15.17%
4 Consumer Staples 10.88%
5 Consumer Discretionary 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AJRD
26
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$19.8M 1.14%
472,828
+87,640
+23% +$4.31M
BHVN
27
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$19.8M 1.14%
580,679
+99,185
+21% +$4.54M
VIAV icon
28
Viavi Solutions
VIAV
$9.41B
$19.5M 1.13%
1,741,403
+83,293
+5% +$1.13M
SAIC icon
29
Saic
SAIC
$4.88B
$19.4M 1.12%
+260,193
New +$21.7M
SAM icon
30
Boston Beer
SAM
$1.86B
$19.3M 1.12%
52,487
+12,830
+32% +$4.76M
EHTH icon
31
eHealth
EHTH
$47.3M
$19.3M 1.11%
136,819
+330
+0.2% +$37.8K
TDOC icon
32
Teladoc Health
TDOC
$1.7B
$19.2M 1.11%
123,955
-68,130
-35% -$7.93M
MC icon
33
Moelis & Co
MC
$5.02B
$18.5M 1.07%
658,846
+193,905
+42% +$6.36M
MRTX
34
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$17.4M 1.01%
226,899
+30,959
+16% +$2.78M
RETA
35
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$16.5M 0.96%
114,536
+12,427
+12% +$2.4M
TNDM icon
36
Tandem Diabetes Care
TNDM
$1.17B
$15.7M 0.91%
244,310
-127,694
-34% -$8.95M
PNFP icon
37
Pinnacle Financial Partners Inc
PNFP
$15.3B
$15.7M 0.91%
417,066
+1,361
+0.3% +$73.7K
MNTV
38
DELISTED
Momentive Global Inc. Common Stock
MNTV
$15.5M 0.9%
1,150,378
+120,640
+12% +$2.07M
GNRC icon
39
Generac Holdings
GNRC
$12.7B
$15.4M 0.89%
+164,818
New +$17M
MTH icon
40
Meritage Homes
MTH
$4.95B
$15.3M 0.88%
835,676
+19,558
+2% +$593K
TWST icon
41
Twist Bioscience
TWST
$5.84B
$15.1M 0.87%
493,476
+160,339
+48% +$4.31M
CCXI
42
DELISTED
ChemoCentryx, Inc.
CCXI
$15.1M 0.87%
374,734
+201,514
+116% +$8.56M
PS
43
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$15.1M 0.87%
1,370,899
+14,373
+1% +$239K
ATRC icon
44
AtriCure
ATRC
$1.77B
$14.3M 0.83%
426,612
-1,907
-0.4% -$68.6K
ADUS icon
45
Addus HomeCare
ADUS
$2.14B
$14.2M 0.82%
210,449
+804
+0.4% +$69.5K
FIVE icon
46
Five Below
FIVE
$11.2B
$14M 0.81%
199,379
-80,688
-29% -$8.21M
MTSI icon
47
MACOM Technology Solutions
MTSI
$20.4B
$13.7M 0.79%
725,743
+177,193
+32% +$4.5M
MODN
48
DELISTED
MODEL N, INC.
MODN
$13.6M 0.79%
614,212
+2,251
+0.4% +$65.8K
TREE icon
49
LendingTree
TREE
$645M
$12.9M 0.75%
70,407
-37,640
-35% -$10.6M
NVEE
50
DELISTED
NV5 Global
NVEE
$12.7M 0.73%
1,229,592
+249,600
+25% +$3.34M

Similar funds

Emerald Advisers's Q1 2020 Portfolio in Review

As of Q1 2020, Emerald Advisers held 369 positions worth $1.73B, down 27% from $2.37B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Emerald Advisers withdrew a net $140M in Q1 2020, closing 156 positions and reducing 96 holdings. Its most notable exit was ForeScout Technologies, Inc. Common Stock, an estimated $25.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.

Against the trend, Emerald Advisers opened a new position in Blueprint Medicines worth $24.3M.

  • Emerald Advisers's largest Q1 2020 buy was Blueprint Medicines: 416,166 shares worth $24.3M.
  • Emerald Advisers added most to TopBuild in Q1 2020, an estimated $13.5M increase.
  • Emerald Advisers's biggest Q1 2020 reduction was American Eagle Outfitters, cutting an estimated $15.7M.
  • Emerald Advisers fully exited ForeScout Technologies, Inc. Common Stock in Q1 2020, selling an estimated $25.7M.
  • Emerald Advisers's ten largest holdings make up 22% of its $1.73B portfolio in Q1 2020.
  • Emerald Advisers opened 31 new positions and closed 156 in Q1 2020.
  • Emerald Advisers's portfolio value fell 27% quarter-over-quarter to $1.73B.

Based on Emerald Advisers's 13F filing for Q1 2020, filed 30 Apr 2020.